No randomised trial of prostate-cancer screening in Norway

Lancet Oncology

Volumn 2, Issue 12, 2001, Pages 741-745

  Fosså, Sophie D ^a   Eri, Lars M ^c   Skovlund, Eva ^a,b   Tveter, Kjell ^c   Vatten, Lars ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; EUROPE; HUMAN; MALE; MEDICAL ETHICS; MEDICAL SOCIETY; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICS; SYMPTOM;

EID: 0035207234     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(01)00588-5     Document Type: Review

References (9)

1. Cancer incidence in five continents: Comparability and quality of data
2. Trends in cancer incidence and mortality
3. Geographic pathology of latent prostatic carcinoma
4. Results of a population-based randomized study of PSA screening for prostate cancer
5. Rationale for randomised trials of prostate cancer screening
6. The prostate cancer intervention versus observation trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer
7. Timely screening routines for prostatic cancer by Norwegian physicians
8. PSA analyses in three Norwegian counties in 1999
9. Ethics of a prostate-cancer screening trial